Masimo Corp

Common Name
Masimo
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
3,600
Ticker
MASI
Exchange
NASDAQ/NGS
Description
Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. ...

Masimo's Financial Statements Preview

Below are the financial statements of Masimo, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenue
Product revenue
1,980.3a
1,954.2a
1,932.8a
Related party revenue
114.1a
93.9a
103a
Total revenue
2,094.4a
2,048.1a
2,035.8a
Cost of goods sold
-1,090a
-1,044.6a
-977a
Gross profit
1,004.4a
1,003.5a
1,058.8a
Operating expenses
Selling, general and administrative
-743.8a
-664a
-657.4a
Research and development
-222.8a
-175.2a
-191.4a
Litigation settlements
-0.5a
-17.8a
0a
Impairment charges, including intangible assets and goodwill
-304a
-10a
0a
Total operating expenses
-1,271.1a
-867a
-848.8a
Operating (loss) income
-266.7a
136.5a
210a
Non-operating loss
-38.6a
-48.4a
-16.6a
(Loss) income before provision for income taxes
-305.3a
88.1a
193.4a
(Benefit) provision for income taxes
-0.4a
6.6a
49.9a
Net (loss) income
-304.9a
81.5a
143.5a
Download Data

Verified Sources Behind Masimo’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Masimo’s data sources below and access millions more through our Disclosure Search.

a. Masimo's 10-K 2024
a. Masimo's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?